Inflammatory Bowel Diseases: New Insights Into Mechanisms of Inflammation and Challenges in Diagnosis and Treatment
This volume contains the proceedings of the 76th Falk Symposium held in Estoril, Portugal, May 5-7, 1994, and presents an aetiopathogenesis-based approach to clinical, diagnostic and therapeutic developments in inflammatory bowel disease. The first section deals with the first results of a prospective epidemiological study in the EEC countries, while subsequent sections cover: the important factors responsible for IBD; diagnosis; controversies in clinical management; and insights into therapy, and difficult clinical problems.
What people are saying - Write a review
We haven't found any reviews in the usual places.
IBD in the north of Portugal
Almada Seixal Sesimbra
Epidemiology of IBD in Vigo health area Spain
27 other sections not shown
Other editions - View all
abdominal acid active Crohn's disease acute antibiotics antibodies antigens arthritis associated autoimmune bacteria biopsies budesonide cancer risk carcinoma CDAI chronic Clin clinical colectomy colitis and Crohn's colonoscopy colorectal cancer controlled trial Crohn's disease cyclosporin cytokines detected diagnosis disease activity distal dose drug dysplasia effect elemental diet endoscopic enema epithelial cells extraintestinal factors faecal fistulas Gastroenterology gene genetic granulocytes histological IBD patients ileal ileum immune Immunol immunosuppressive incidence increased induced inflammation inflammatory bowel disease interleukin intravenous lesion leucocyte macrophages mediators mesalazine metabolism methotrexate mucosal Mycobacterium paratuberculosis neutrophils nutrition oral paratuberculosis pathogenesis patients with Crohn's patients with IBD patients with ulcerative population pouchitis present proctitis protein rats receptor rectal rectum recurrence relapse remission resection response role Scand J Gastroenterol side-effects specific steroids strictures sulphide surgery surgical symptoms Table therapeutic therapy tissue toxic megacolon treatment ulcerative colitis ulcerative colitis patients